Veyong ngliwati audit EU Edqm sepisan maneh

Tanggal 22 April, kabar apik teka! Hebei Veyong Pharmaceutical Co, Ltd Sawise maneh sukses entuk sertifikasi EU CepivermectinAPI sing ditanggepi dening agensi Eropa kanggo kualitas obat (edqm).

IvermectinAPI minangka salah sawijining produk utama Veyong Pharma. Ditampa kanthi becik para pelanggan ing omah lan ing luar negeri amarga stabilitas sing kuwat, proses produksi berkualitas tinggi lan ijo. Ing 2018, sukses entuk sertifikasi FDA AS.

Sertifikat cep ivermectin minangka sertifikat adaptasiia Pharmacopoeia Eropa, sing ora mung dikenali dening kabeh negara anggota EU, nanging uga dikenali dening akeh negara sing ngerteni status pharmacopoeia Eropa. Obtaining the CEP certificate again is the recognition of Veyong Pharma's products in the international market, the embodiment of Veyong's market competitiveness, and a significant sign of achieving high-quality business development in overseas markets.